Glycerin

Glycerin

SCHEMBL4958002

O=C(O)CCCS.O=C(O)CCCS.O=C(O)CCCS.OCC(O)CO

nearest known ligand 0.68

Full drug profile on Sugi Atlas →

Predicted protein targets (top 13)

geneUniProtsupporting neighboursconfidence
FOLH1 Q04609 4/20 0.58
CAMK2A Q9UQM7 1/20 0.44
LMNA P02545 4/20 0.43
SLC22A6 Q4U2R8 1/20 0.43
ENPEP Q07075 3/20 0.42
GSTK1 Q9Y2Q3 2/20 0.42
TSHR P16473 1/20 0.42
NFKB1 P19838 1/20 0.42
PMP22 Q01453 1/20 0.42
ALDH1A1 P00352 1/20 0.41
GPR84 Q9NQS5 1/20 0.41
FFAR1 O14842 1/20 0.41
FFAR4 Q5NUL3 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Glycerin SCHEMBL4958965 0.93 FOLH1 (0.70) FOLH1CAMK2ALMNASLC22A6ENPEP
Glycerin SCHEMBL4959228 0.91 FOLH1 (0.67) FOLH1LMNAENPEPGSTK1TSHR
Mercaptopropionic Acid SCHEMBL15379303 0.86 ACE (0.48) FOLH1LMNASLC22A6ENPEPALDH1A1
Mercaptopropionic Acid SCHEMBL22031777 0.86 ACE (0.48) FOLH1LMNASLC22A6ENPEPALDH1A1
Mercaptopropionic Acid SCHEMBL538146 0.86 ACE (0.48) FOLH1LMNASLC22A6ENPEPALDH1A1
Mercaptopropionic Acid SCHEMBL2227708 0.86 ACE (0.48) FOLH1LMNASLC22A6ENPEPALDH1A1
Mercaptopropionic Acid SCHEMBL331248 0.86 ACE (0.48) FOLH1LMNASLC22A6ENPEPALDH1A1
Glutarate SCHEMBL22490703 0.85 SLC22A6 (0.61) FOLH1CAMK2ALMNASLC22A6TSHR
Adipic Acid SCHEMBL28688445 0.85 LMNA (0.61) FOLH1CAMK2ALMNASLC22A6TSHR
Adipic Acid SCHEMBL270756 0.85 LMNA (0.61) FOLH1CAMK2ALMNASLC22A6TSHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20080206153-A1 Copolymers for Cosmetic Agents, Produced in the Presence of Polyfunctional Chain Transfer Agents BASF AKTIENGESELLSCHAFT (DE) 2008-08-28 US disclosed
EP-1844081-A1 COPOLYMERS FOR COSMETIC AGENTS, PRODUCED IN THE PRESENCE OF POLYFUNCTIONAL CHAIN TRANSFER AGENTS BASF AKTIENGESELLSCHAFT (DE) 2007-10-17 EP disclosed
WO-2006077144-A1 COPOLYMERS FOR COSMETIC AGENTS, PRODUCED IN THE PRESENCE OF POLYFUNCTIONAL CHAIN TRANSFER AGENTS BASF AKTIENGESELLSCHAFT (DE) 2006-07-27 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080206153-A1 Copolymers for Cosmetic Agents, Produced in the Presence of Polyfunctional Chain Transfer Agents ACOX3, PAOX, ACOT7 FOLH1 4128/4885CAMK2A 3929/4885LMNA 3541/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.